Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C F Punzi
Once-Daily Eprosartan Mesylate in the Treatment of Elderly Patients With Isolated Systolic Hypertension: Data From a 13-Week Double-Blind, Placebo-Controlled, Parallel, Multicenter Study
Journal of Human Hypertension
Internal Medicine
Related publications
Corrections To: Once-Daily Controlled-Release Pregabalin in the Treatment of Patients With Fibromyalgia: A Phase III, Double-Blind, Randomized Withdrawal, Placebo-Controlled Study
Current Medical Research and Opinion
Medicine
Ketanserin in Essential Hypertension: A Double-Blind, Placebo-Controlled Study.
Postgraduate Medical Journal
Medicine
Lithium as Add-On to Quetiapine XR in Adult Patients With Acute Mania: A 6-Week, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study
International Journal of Bipolar Disorders
Psychiatry
Mental Health
Biological Psychiatry
Clinical Efficacy of Fidarestat, a Novel Aldose Reductase Inhibitor, for Diabetic Peripheral Neuropathy: A 52-Week Multicenter Placebo-Controlled Double-Blind Parallel Group Study
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
A Phase II, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
BP-C1 in Treatment of Patients With Stage IV Breast Cancer: A Randomized, Double-Blind, Placebo-Controlled Multicenter Study and Additional Open-Label Treatment Phase.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
A Double - Blind, Placebo - Controlled, Randomized Study Comparing Quetiapine With Placebo, Along With Oral Naltrexone, in the Treatment of Opioid Dependent Patients
Journal of Evolution of Medical and Dental Sciences
N-Acetyl Cysteine (NAC) in the Treatment of Obsessive-Compulsive Disorder: A 16-Week, Double-Blind, Randomised, Placebo-Controlled Study
CNS Drugs
Psychiatry
Mental Health
Neurology
Pharmacology
Dose-Dependent Effects of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes Inadequately Controlled With Metformin: A Randomized, Double-Blind, Placebo-Controlled Trial
Diabetic Medicine
Internal Medicine
Endocrinology
Metabolism
Diabetes